LncRNA-BLACAT1 Facilitates Proliferation, Migration and Aerobic Glycolysis of Pancreatic Cancer Cells by Repressing CDKN1C Via EZH2-Induced H3K27me3

Overview

Journal Front Oncol

Specialty Oncology

Date 2020 Oct 19

PMID 33072570

Citations 22

Authors

Xin Zhou

Wei Gao

Huanhuan Hua

Zhimin Ji

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the role of lncRNA-BLACAT1 in promoting H3K27 trimethylation of CDKN1C gene by recruiting EZH2 to regulate CCNE on glycolysis and mitochondrial oxidative phosphorylation of pancreatic cancer (PC) cells.

Methods: Following bioinformatic prediction, EZH2 and BLACAT1 in PC cells were interfered, and cells proliferation, migration and invasion in each group were detected. Western blotting detected the expression of key proteins of mitochondrial complex. The sub-cellular localization of BLACAT1 was tested, followed by testing the binding of CDKN1C and BLACAT1 with EZH2, followed by verification.

Results: Based on bioinformatic prediction, EZH2 and BLACAT1 were highly expressed in PC, while CDKN1C was lowly expressed (all < 0.05). Interference with EZH2 and BLACAT1 inhibited cell proliferation, migration and aerobic glycolysis, and promoted mitochondrial oxidative phosphorylation (all < 0.05). BLACAT1 promoted H3K27 trimethylation of CDKN1C through recruiting EZH2 (all < 0.05). results showed that BLACAT1 interference inhibited tumor formation (all < 0.05).

Conclusion: Interference with BLACAT1 inhibits H3K27 trimethylation of CDKN1C gene by blocking EZH2 recruitment to promote CDKN1C expression and inhibit CCNE expression, thus suppressing PC cell proliferation, migration and aerobic glycolysis, and promoting mitochondrial oxidative phosphorylation.

Citing Articles

Mutation on JmjC domain of UTX impaired its antitumor effects in pancreatic cancer via inhibiting G0S2 expression and activating the Toll-like signaling pathway.

Shen X, Xiong S, Wang S, Lu S, Wan Y, Zhang H Mol Med. 2024; 30(1):258.

PMID: 39707168 PMC: 11660670. DOI: 10.1186/s10020-024-01023-2.

The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression.

Xu F, Xu X, Deng H, Yu Z, Huang J, Deng L Transl Oncol. 2024; 49:102104.

PMID: 39197387 PMC: 11399563. DOI: 10.1016/j.tranon.2024.102104.

A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition.

Zhong W, Fu J, Liao J, Ouyang S, Yin W, Liang Y Int Urol Nephrol. 2023; 56(6):1987-1999.

PMID: 38097887 DOI: 10.1007/s11255-023-03892-8.

Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway.

Liang G, Han L, Qu M, Xue J, Xu D, Wu X Aging (Albany NY). 2023; 15(23):13655-13668.

PMID: 38048186 PMC: 10756104. DOI: 10.18632/aging.205197.

The clinicopathological and prognostic significances of EZH2 expression in urological cancers: A meta‑analysis and bioinformatics analysis.

Bai Y, Sun J, Wang Y, Zheng N, Xu Q, Wang Y Oncol Lett. 2023; 26(1):315.

PMID: 37346412 PMC: 10280112. DOI: 10.3892/ol.2023.13902.

References

Chen Z, Yang P, Li W, He F, Wei J, Zhang T . Expression of EZH2 is associated with poor outcome in colorectal cancer. Oncol Lett. 2018; 15(3):2953-2961. PMC: 5778885. DOI: 10.3892/ol.2017.7647. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Dassanayake D, Muthunayake T, Senevirathna K, Siribaddana A . Staging of lung cancer in a tertiary care setting in Sri Lanka, using TNM 7th edition. A comparison against TNM6. BMC Res Notes. 2012; 5:143. PMC: 3327630. DOI: 10.1186/1756-0500-5-143. View

Chen W, Hang Y, Xu W, Wu J, Chen L, Chen J . BLACAT1 predicts poor prognosis and serves as oncogenic lncRNA in small-cell lung cancer. J Cell Biochem. 2018; 120(2):2540-2546. DOI: 10.1002/jcb.27548. View

Carlson C, Kim K . Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation. J Biol Chem. 1973; 248(1):378-80. View

Wu X, Zheng Y, Han B, Dong X . Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361. Biomed Pharmacother. 2018; 99:832-838. DOI: 10.1016/j.biopha.2018.01.130. View

Omazic B, Ayoglu B, Lohr M, Segersvard R, Verbeke C, Magalhaes I . A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer. J Immunother. 2017; 40(4):132-139. DOI: 10.1097/CJI.0000000000000164. View

Li X, Qi S, Ma D, Fan J, Wang J . Long non-coding RNA BLACAT1 promotes the proliferation and invasion of glioma cells via Wnt/β-catenin signaling. Exp Ther Med. 2019; 17(6):4703-4708. PMC: 6489056. DOI: 10.3892/etm.2019.7468. View

Bose S, Le A . Glucose Metabolism in Cancer. Adv Exp Med Biol. 2018; 1063:3-12. DOI: 10.1007/978-3-319-77736-8_1. View

10.

Fujii S, Ito K, Ito Y, Ochiai A . Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation. J Biol Chem. 2008; 283(25):17324-32. PMC: 2427338. DOI: 10.1074/jbc.M800224200. View

11.

Guillen-Ponce C, Blazquez J, Gonzalez I, de-Madaria E, Montans J, Carrato A . Diagnosis and staging of pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2017; 19(10):1205-1216. DOI: 10.1007/s12094-017-1681-7. View

12.

Hatzivassiliou G, Zhao F, Bauer D, Andreadis C, Shaw A, Dhanak D . ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005; 8(4):311-21. DOI: 10.1016/j.ccr.2005.09.008. View

13.

Singh K, Hahm E, Rigatti L, Normolle D, Yuan J, Singh S . Inhibition of Glycolysis in Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate. Cancer Prev Res (Phila). 2018; 11(6):337-346. PMC: 5984685. DOI: 10.1158/1940-6207.CAPR-17-0389. View

14.

Yuan J, Ng W, Yap J, Chia B, Huang X, Wang M . The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho-Ser-621 in the C terminus of CRAF. J Biol Chem. 2018; 293(37):14276-14284. PMC: 6139560. DOI: 10.1074/jbc.RA118.004597. View

15.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

16.

Wang X, Long Y, Paucek R, Gooding A, Lee T, Burdorf R . Regulation of histone methylation by automethylation of PRC2. Genes Dev. 2019; 33(19-20):1416-1427. PMC: 6771386. DOI: 10.1101/gad.328849.119. View

17.

Dong Z, Wang Y . LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3. Pathol Res Pract. 2019; 215(3):571-579. DOI: 10.1016/j.prp.2019.01.017. View

18.

Dai D, Feng X, Zhu W, Bao Y . LncRNA BLACAT1 regulates the viability, migration and invasion of oral squamous cell carcinoma cells by targeting miR-142-5p. Eur Rev Med Pharmacol Sci. 2019; 23(23):10313-10323. DOI: 10.26355/eurrev_201912_19669. View

19.

Wu J, Zhang X, Wang Y, Sun Q, Chen M, Liu S . Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway. Oncol Rep. 2017; 39(3):1181-1190. DOI: 10.3892/or.2017.6155. View

20.

Mallen-St Clair J, Soydaner-Azeloglu R, Lee K, Taylor L, Livanos A, Pylayeva-Gupta Y . EZH2 couples pancreatic regeneration to neoplastic progression. Genes Dev. 2012; 26(5):439-44. PMC: 3305982. DOI: 10.1101/gad.181800.111. View